Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture

NCT03219307 is registered in ClinicalTrials.gov with Aesculap Biologics, LLC as lead sponsor.

NCT NCT03219307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03219307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture
Lead sponsor
Aesculap Biologics, LLC
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 30, 2018
Completion date
January 31, 2029
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage defect